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Abstract
General complexities in versatile animals are not always proportional to their genome
size. A notable example is that the salamander genome size is 15-fold larger than that of
human, which mostly contains unfolded “junk DNA.” A vast portion of this non-protein-
coding unfolded DNA undergoes transcriptional regulation and produces a large num‐
ber of long noncoding RNAs (lncRNAs). LncRNAs play key roles in gene expression and
therapies of different human diseases. Recently, novel lncRNAs and their function on the
silencing or activation of a particular gene(s) are regularly being discovered. Another im‐
portant component of gene regulation is high packing of chromatin, which is composed
of mainly repetitive sequences with negligible coding potential. In particular, an epige‐
netic marker determines the state of the gene associated with it, whether the gene will be
expressed or silenced. Here, we elaborately discuss the biogenesis pathway of lncRNAs
as well as their mechanism of action and role in gene silencing and regulation, including
RNA interference. Moreover, several lncRNAs are the common precursors of small regu‐
latory RNAs. It is thus becoming increasingly clear that lncRNAs can function via numer‐
ous paradigms as key regulatory molecules in different organisms.
Keywords: Transcriptional silencing, long noncoding RNA, cancer, neurological disor‐
der, Drosophila
1. Introduction
Since the earliest days of molecular biology, RNA-mediated gene regulation was known to the
researchers, and it was first suggested that noncoding RNA (ncRNA) might have a role in gene
regulation by interacting with promoters [1, 2]. After more than four decades of research, the
discovery of RNA interference (RNAi) has revolutionized our perception of the mechanism of
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gene regulation, organization of chromosomes, and epigenetic regulations. Important clues to
ncRNA regulatory mechanisms came from homology-dependent gene silencing in plants,
which can be initiated by transgenes and recombinant viruses [3]. Studies on the nematode
Caenorhabditis elegans, the fruit fly Drosophila melanogaster [4], fungi mainly yeast, mammalian
cells, and plants revealed transcriptional silencing mechanisms involving RNAi, chromatin,
and its various modifications [3]. RNAi operates mainly posttranscriptionally; however, its
components are associated with transcriptional gene silencing and heterochromatin forma‐
tion, too [5].
Recent findings have made it clear that transcriptional gene silencing (TGS), posttranscrip‐
tional gene silencing (PTGS), and chromatin modifications are utilized by eukaryotic cells to
bring about endogenous gene regulation, chromosome organization, and nuclear clustering.
The RNA interference mechanisms mainly target the transposable elements, which are
abundant and perhaps a defining component of heterochromatin. The role of ncRNA in dosage
compensation, inactivation of X chromosome, genomic imprinting, polycomb silencing, and
blocking of interactions between enhancers and promoters by chromatin insulators is well
proven. Although the studies strongly point towards the involvement of RNAi, its role has not
been demonstrated directly [6].
The non-protein-coding transcripts longer than 200 nucleotides are known as long noncoding
RNAs to differentiate superficially this class of ncRNAs from microRNAs, short interfering
RNAs, piwi-interacting RNAs, small nucleolar RNAs, etc [7]. LncRNAs have emerged as
important regulators of cell physiology and pathology. Different studies have come up with
an increasing number of lncRNAs showing tissue-specific expression; however, the exact
mechanism of action of only a few lncRNAs has been elucidated in vivo [8–14]. The biological
functions and mechanisms of action of the majority of lncRNAs still remain unknown.
LncRNAs can interact with a wide range of molecules and can form RNA-RNA, RNA-DNA,
or RNA-protein complexes through specific RNA functional domains [15], resulting in
extensive functional diversities. Recent research focuses on lncRNAs and divulges the
association of lncRNAs with epigenetic machinery to control chromatin structure, nuclear
clustering, and gene expression. The studies reveal that lncRNAs may act together with many
histone- and DNA-modifying enzymes to modify the histones or DNA. In addition, a recent
discovery of a cardioprotective lncRNA showed a targeting mechanism through ATP-
dependent chromatin remodeling factors [16], indicating an extensive role of lncRNAs in
chromatin structure and regulation. The mechanisms of how lncRNAs control chromatin by
covalent modifications are extensively reviewed in the literature [17–20].
The study of lncRNAs has taken the center stage for the researchers working with epigenetic
regulations, and there is a report of a new lncRNA regulating a disease, or transcriptome
studies come up with a new class of noncoding RNA, or we are introduced to hitherto
unknown mechanisms by which an lncRNA regulates a particular gene almost on a weekly
basis. These are all possible due to the introduction of many advanced, high-throughput
genomic technologies such as microarrays and next-generation sequencing (NGS). There are
a huge number of reported lncRNAs that are not derived from protein-coding genes, and in
spite of this vast number of reports on lncRNA, we have just started getting a clear picture
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about how lncRNAs function, how many different types of lncRNAs exist, and how many of
the reported lncRNAs are biologically important.
2. The C-value enigma and junk DNA
It  has  long  been  known  that  developmental  complexity  or  size  of  an  animal  does  not
correspond with C-value or the amount of DNA in the haploid genome [21–23]. The lower
animal in the evolution ladder, salamander, has a genome size 15 times larger than that of
humans [21], and this discrepancy is known as the “C-value paradox” [23]. Since the introns
were discovered, we started to presume that the C-value paradox was now solved [24]. We
are  almost  sure  that  humans  have  about  25,000–35,000  protein-coding  genes  unlike  the
overestimates of 50,000–100,000 from the initial days of the Human Genome Project [25].
The remaining huge amount of noncoding DNA was termed as “junk DNA” [24, 26] due
to the presence of transposons, pseudogenes, and simple repeats, which occupies about 50–
70% of the human genome [27]. C-value enigma poses a discrepancy in genome size and
number  of  protein-coding genes.  Phylogenetically  close  genera  may vary  in  C-value  by
around four- to five fold [28].
In spite of their “junk” status, scientists were always curious to study them and even realized
that “being junk doesn’t mean it is entirely useless” [26]. It was hypothesized that the junk
DNA might be useful in chromosomal pairing, genome integrity, gene regulation, mRNA
processing, and serving as a reservoir for evolutionary innovation. We are now pleasantly
surprised at their foresight. In the 1970s, it was already thought that noncoding RNA products,
such as rRNAs, tRNAs do not make up the whole transcribed genome.
The scale of “pervasive transcription,” however, was not fully appreciated until the late 1990s
and early 2000s. After the arrival of whole-genome technologies, from microarray hybridiza‐
tion and deep sequencing analysis techniques, it was recently shown that 70–90% of our
genome is transcribed at some point during embryogenesis [29]. Some recently identified
transcripts may be present at as low as 0.0006 copies per cell [30]. Another concern is that tiling
microarrays can come up with false positives, low dynamic range, resolution, and low
concordance between studies [31]. The existence of noncoding transcription in intergenic
regions is evident from correlations with chromatin signatures, such as DNase1 hypersensi‐
tivity, and histone modifications such as H3K9ac, H3K4me3, and H3K36me3 [31]. Although
these studies report novel and conserved lncRNAs, that is not enough to explain the function
of 70–90% of the genome and biological functionality of the ncRNAs. In 1969, Britten and
Davidson presented a model for regulation of gene expression in eukaryotic cells where
ncRNAs have important roles as regulatory intermediaries to convey signals from sensory to
receptor elements [1]. Some of the first examples of gene-specific regulatory roles of lncRNAs
were revealed with the discovery of lncRNAs involved in epigenetic regulation, such as H19
[32] and X-inactive specific transcript (Xist) [33, 34].
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3. Stand-alone lncRNAs
These lncRNAs are located as separate units and do not overlap protein-coding genes. Some
of these are known as lincRNAs for large intergenic (or intervening) noncoding RNAs
(lincRNAs) [35]. Many of the lincRNAs were identified through chromatin signatures for
actively transcribed genes (H3K4me3 at the promoter and H3K36me3 along the transcribed
length). Many of the characterized lncRNAs are transcribed by RNA Pol II, polyadenylated,
and spliced and have an average length of 1 kb.
4. Natural antisense transcripts
In this study, transcription occurs in the antisense strand of annotated transcription units;
about 70% of sense transcripts have reported antisense counterparts [36]. The overlap between
these sense/antisense pairs can be a complete sequence, but natural antisense transcripts are
mostly found to be enriched around the 5′ promoter or 3′ terminator ends of the sense
transcript. The most extensively studied example of sense/antisense pairing is Xist/Tsix
(lncRNA antisense to Xist), with two RNAs that control X chromosome inactivation [37]. In
addition, many imprinted regions contain coding/noncoding sense/antisense pairs, such as
Kcnq1 (potassium channel, voltage-gated KQT-like subfamily Q, member 1)/Kcnq1ot1 (Kcnq1
overlapping transcript 1) [38] and Igf2r (insulin-like growth factor 2 receptor)/Air (antisense
Igf2r RNA) [39]. These pairs are generally less spliced or polyadenylated when compared to
mRNAs or stand-alone lncRNAs.
5. Long intronic ncRNAs
Introns have long been known to contain small ncRNAs such as small nucleolar RNAs
(snoRNAs) and microRNAs (miRNAs). However, by large-scale transcriptomic or computa‐
tional analyses, many long transcripts have been reported to be encoded within the introns of
known genes [40]. Although they have differential expression patterns and respond to the
environmental stimuli differently, only a few have been extensively studied to date. One such
example is cold-assisted intronic noncoding RNA (COLDAIR) that has been implicated in
plant vernalization, which is located in the first intron of the flowering repressor locus FLC [41].
6. Identification of long noncoding RNAs
LncRNAs are identified by transcripts that map to genomic regions outside the boundaries of
protein-coding genes. It is difficult to ascertain the function of a transcript that overlaps a
protein-coding gene using targeted knockout or knockdown approaches. Thus, most experi‐
mental investigations of lncRNAs have been focused on those that are located in intron
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sequences. It is also very difficult to ascertain whether an lncRNA locus is entirely intergenic
because lncRNA transcripts are often incomplete and they can originate from a protein-coding
gene’s promoter or enhancer on either strand [42]. Tiling microarray technique is often useful
to detect intergenic transcripts [43]. However, controversial results were found here and these
experiments can be ruled out [31]. Early lncRNA collections relied primarily on sequenced
cDNA and EST clones [44]. More recently, RNA-Seq has come up with a number of lncRNAs
derived from whole transcriptome sequencing. RNA-Seq generates millions of 35–100 nt
sequences read in parallel, and it has been confirmed that a large chunk of intergenic sequences
are transcribed into lncRNAs [45]. The high-throughput and impartial nature of this technique
is being utilized for the detailed assessment of the contribution of lncRNAs to a variety of tissue
and/or species under different conditions.
To accurately distinguish noncoding from coding transcripts, sophisticated approaches have
been developed. For example, the Coding Potential Calculator [46] takes into account six features
of a transcript, including the proportion of the transcript enclosed by the candidate peptide-
encoding region, and the sequence similarity to known proteins. An evolutionary approach,
followed in phyloCSF, predicts ncRNAs when their sequence differences among species do not
show preference as to whether they disrupt or not putatively encode peptides [47].
Experimentally determined transcripts always are relied on more than predicted ones. The
availability of large proteomic databases can be utilized to investigate whether a specific RNA
molecule is translated into a protein. In vitro translation assays have been used, too, but they
do not necessarily reflect in vivo biology. A true lncRNA should not bind with translation
machinery, and this approach is also adopted in the identification of candidate lncRNA.
However, a study has reported that 50% of a set of putative lncRNAs are ribosome associated
[48], leaving in doubt whether this test is accurate in separating coding from noncoding
transcripts. To assign an lncRNA, an experimental determination of the function of a transcript
will be necessary. Nevertheless, some transcripts possess both RNA- and coding-sequence-
dependent functions [49] and demarcating them will be difficult. A computational or experi‐
mental method has not yet been developed that discriminates accurately between coding and
noncoding transcripts. For the time being, we can rely on in silico screens for the protein-coding
potential of putative lncRNAs but be aware that these will contain false-positive predictions,
too, especially for genes that encode short polypeptides.
Although many genomes contain a substantial number of lncRNA loci, we still do not know
the proportion and number of these that are biologically functional. Because the functional
mechanisms of most noncoding transcripts or transcript regions are unknown, it is difficult to
design point mutation or deletion experiments and their results are difficult to interpret. Even
RNAi techniques are not being helpful to assign the functionality of the ncRNAs.
7. Mechanisms of action
We do not know yet the mechanistic detail of the enormous number of reported lncRNAs.
However, a few that have been thoroughly studied provide clues regarding how lncRNAs
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might carry out gene regulation (Figure 1). In addition, many lncRNAs blur the line of different
categories and employ several different mechanisms. The discovery of new lncRNAs and more
thorough characterization of those already known will reveal additional modes of action.
It has been found that a major role of lncRNA is to recruit regulatory proteins for the regulation
of chromatin states [50]. This kind of lncRNAs may act in cis, on adjacent or nearby genes, or
they might act in trans, regulating genes located in distant domains or chromosomes. Polycomb
repressive complex 2 (PRC2) interacts with a large number of lncRNAs [51–54]. The Drosophi‐
la polycomb proteins, first discovered as homeotic gene, express during development [55, 56].
These include enhance of zeste homolog 2 (Ezh2, catalytic subunit in PRC2), which is a key
H3K27 methyltransferase, and the Pc/Chromobox (Cbx) family proteins in PRC1, chromodo‐
main-containing proteins that can bind trimethylated H3K27 [55, 56]. Observed interactions
of polycomb proteins with lncRNAs suggest that polycomb recruitment is RNA directed in
mammals. HOX transcript antisense RNA (HOTAIR) in the homeobox (HOX) C cluster is
reported to repress transcription of HOXD in trans through interaction with PRC2 [57]. Xist
RNA-containing repeat A (RepA) has been found to recruit PRC2 [58]. RepA targets PRC2 to
the Xist promoter resulting in Xist up-regulation. The interesting fact is that RepA/Xist
interaction with PRC2 may be blocked by the antisense Tsix transcript, also interacting with
PRC2 and competitively inhibiting the painting of Xist on inactive X chromosome [58].
Other epigenetic complexes interact with lncRNAs as well, such as the H3K9 methyltransferase
G9a interacting with the imprinted lncRNA Air [59]. Kcnq1ot1 has been hypothesized to recruit
both PRC2 and G9a to the promoter of Kcnq1 [60] acting as a scaffold. On the other hand,
antisense ncRNA in the INK4 locus (ANRIL), associated with p15/INK4 (inhibitors of CDK4
family) B-p16/INK4A-p14/ARF tumor suppressor gene cluster, interacts with both the PRC1
component Cbx7 and the PRC2 component Suz1 [61, 62]. HOTAIR also interacts with the
lysine-specific demethylase 1 (LSD1)/corepressor protein of LSD1 (CoREST)/repressor for
element 1-silencing transcription factor (REST) complex in addition to PRC2 to prevent gene
activation [63].
LncRNAs can also act by recruiting factors involved in gene activation. Such factors from the
HOXA (homeotic gene A cluster), two lncRNAs, Mistral (Mira), and HOXA transcript at the
distal tip (HOTTIP) have been involved in recruiting the mixed lineage leukemia (MLL)
complex in cis regulation [64, 65].
An H3K4 trimethylase, myeloid/lymphoid or mixed-lineage leukemia (MLL), is a member of
the Trithorax group of developmentally important gene-activating proteins in flies [66]. Using
3C or chromosome conformation capture technique, it was found that multiple loci, which are
40 kb apart in the HOXA cluster, are in close physical proximity, enabling MLL to regulate
their expression. Other than histone modifications, lncRNAs also impact epigenetic regulation
by modulating DNA methylation at CpG dinucleotides, which has an important role in the
stable repression of genes [67]. During embryogenesis, methylation markers are first to be
found on previously unmethylated DNA by the DNA (cytosine-5-)-methyltransferase 3α
(Dnmt3a) and 3β (Dnmt3b) and later maintained through DNA replication by Dnmt1. Tsix
might be converted to Xist by utilizing Dnmt3a activity to methylate and finally silence the
Xist promoter [68, 69]. In the same way, Kcnq1ot1 may recruit Dnmt1 [70].
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LncRNA-directed methylation has also been implicated in the regulation of rDNA. Ribosomal
DNA exists in the genome as tandem repeat units [71]. Each unit encodes a polycistronic
transcript consisting various rRNAs, and each unit is separated by intergenic spacers (IGSs)
transcribed by RNA Pol I [72]. Recently, it was reported that IGS transcripts undergo proc‐
essing into 150- to 300-nt fragments called promoter (p)RNAs, which act as scaffolds to recruit
poly (ADP ribose)-polymerase-1 (PARP1) [73], the ATP-dependent nucleolar chromatin
remodeling complex (NoRC) [74], and Dnmt3b [75]. A conserved hairpin structure is formed
by pRNA that binds both PARP1 and the TIP5 subunit of NoRC, leading to TIP5 conformation
change resulting in the recruitment of NoRC to the nucleolus, where rDNA is located [74, 76].
The interesting fact is that the recruitment of Dnmt3b by pRNA is dependent on DNA:RNA
triplexing, possibly via Hoogsteen base pairing, between the 5′ end of pRNA and the rDNA
promoter [75]. The DNA:RNA triplex formation might be a general mechanism by which
lncRNAs recruit trans factors to specific DNA loci. LncRNAs are intrinsically bound to
chromatin during transcription and transcribed from a single locus in the genome, so they
have a direct allele- and locus-specific control in cis unlike transcription factors. The length of
lncRNAs is also suitable to reach out and capture epigenetic marks. This cis-acting mechanism
Figure 1. Mechanisms of lncRNA function (modified from Kung et al. [129]).
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resembles transcriptional gene silencing seen in the yeast Schizosaccharomyces pombe in
assembling centromeric heterochromatin [77, 78].
The nucleus is always in the dynamic state and is the center for most of the essential functions
of an organism [79]. Recent studies indicate that lncRNAs are the key regulators of nuclear
compartments. The structure and function of several nuclear bodies seem to be controlled by
RNA. One example is nuclear-enriched abundant transcript 1 (NEAT1) that maintains the
stability of paraspeckles, which participate in the nuclear retention of mRNAs after adenosine-
to-inosine hyperediting [80, 81]. NEAT1 interacts with paraspeckle proteins, such as p54/
NONO and PSP [80–82] and recruits these proteins to form paraspeckles. This is an active
process where continuous transcription of NEAT1 is required [84]. The related molecules,
NEAT2 or metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), are involved
in the localization of serine/arginine (SR) splicing factors to nuclear speckles where they can
be stored and later modified by phosphorylation [85]. MALAT1 directs these splicing factors
to sites of transcription, ultimately controlling the alternative splicing of certain mRNA
precursors [86]. MALAT1 interacts with the PRC1 subunit Cbx4/Pc2 and participates in the
transportation of genes between nuclear compartments for silencing and activation. Extracel‐
lular growth signals help unmethylated Cbx4 to bind MALAT1 and localize its target genes,
along with Lysine (K)-specific demethylase 1A (LSD1) to interchromatin granules that usually
cluster around nuclear speckles. However, Cbx4 gets methylated in the absence of extracellular
signal and instead binds another lncRNA TUG1, then binds with Ezh2, and translocates to
silencing compartments called polycomb bodies [87]. Although these recent observations have
started to open up an avenue to understand lncRNA and their mechanisms of action, we are
still way behind. The function of an overwhelming number of lncRNAs that are being
discovered almost daily is unknown until now.
8. Epigenetic regulation
The two most abundant modes of action of lncRNAs are the modulation of chromatin by
recruiting histone proteins and transcription factors within specific chromatin-modifying
complexes. A very good example of recruitment of specific histones is X chromosome inacti‐
vation (XCI), which is caused by “Xist” as described in the earlier section [58]. A similar event
is genomic imprinting, where genes are expressed from the allele of only one parent. One of
the first and best studied lncRNAs is H19, which is mutually imprinted with insulin-like
growth factor 2 (Igf2). This lncRNA is highly expressed, but its deletion has no phenotypic
outcome, and it is anticipated to function as a microRNA precursor [88]. Other lncRNAs (e.g.,
Air, Kcnq1ot1, and HOTAIR) show modulatory activities both in cis or in trans and regulating
gene expression through partnering with chromatin-modifying complexes [70, 89]. Specifical‐
ly, HOTAIR is a trans-acting lncRNA that serves as a scaffold for two histone modification
complexes: it binds both to PRC2 and to LSD1 [63]. In the Arabidopsis plant, it was found that
different environmental conditions are able to induce the transcription of related NATs (i.e.,
COOLAIR) that eventually silence a flower repressor locus, flowering locus c (FLC) [90].
Recently, it was discovered that lncRNA, namely COLDAIR, bearing minor differences from
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COOLAIR (transcribed in the sense direction relative to FLC mRNA transcription), interacts
on its own with PRC2 and targets it to FLC [41]. Other trans-acting lncRNAs have different
functions, some of which remain incompletely defined. There are several poorly defined
trans-acting lncRNAs, such as the p21-associated ncRNA DNA damage activated (PANDA),
which is induced upon DNA damage in a p53-dependent manner and it controls the expression
of proapoptotic genes [91].
9. Transcriptional regulation
The discovery and characterization of promoter-associated RNAs opened up a new under‐
standing on how genes are regulated during transcription. These RNAs are localized within
the promoter and consist of various sizes of RNA molecules [92]. The long ones are found at
a single-gene level and are associated with the modification of DNA methylation and deme‐
thylation patterns [93] as mentioned earlier. Interestingly, long (antisense) pRNAs generally
form double-stranded molecules that are processed into endo-siRNAs, and since they have
sequence complementarity with the promoter, they induce transcriptional gene silencing [20,
94–96] or activation [97–99].
LncRNAs sometimes affect transcription by acting as coregulators or by regulating the
association and activity of coregulators. One example is embryonic ventral forebrain-2 (Evf-2)
that functions as a coactivator for the homeobox transcription factor distal-less homeobox 2
(Dlx2) [100].
10. Posttranscriptional regulation
lncRNAs not only have a role in transcription but also they function in splicing, mRNA
stability, and translation. Antisense lncRNA sometimes bind to the sense RNA, conceal the
splice sites, and thereby modify the balance between splice variants. Antisense transcript
RevErbAα modifies the splicing of thyroid hormone receptor alpha genes (TRα) TRα1 and
TRα2 mRNAs [101].
The terminal differentiation-induced ncRNA (TINCR) associates with Staufen 1 but not with
the complex between TINCR-NA, which is a differentiation factor [102].
LncRNAs have also been implicated in translational regulation. An example is the antisense
for PU1 mRNA. Its translation is inhibited by an antisense polyadenylated lncRNA with a half-
life longer than the original transcript [103]. Another example is the lncRNA Uchl1, which is
controlled by mammalian target of rapamycin (mTOR) pathway, shuttles from the nucleus to
the cytoplasm, and controls the translation of the ubiquitin carboxy-terminal hydrolase L1
(UCHL1) mRNA by promoting its association with polysomes [104].
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11. Role of lncRNAs in cancer and other human diseases
The genome-wide association studies identify several cancer risk loci outside of protein-
coding regions. Of 301 single-nucleotide polymorphisms currently linked to cancer, only 12
(3.3%) modify the amino acid sequence of the protein, and most of the loci are located in
the introns (40%) or intergenic regions (44%) [105]. These facts and the observations that
miRNA and lncRNAs are involved in differentiation and development point towards the
fact that alterations in their expression profiles could be correlated with cancer develop‐
ment. Reports suggested that lncRNAs have tissue-specific expression and is found to be
deregulated  in  distinct  types  of  cancers.  For  example,  overexpression  of  miR-155  was
reported  in  hematopoietic,  breast,  lung,  and  colon  cancers  [106],  whereas  miR-21  is
overexpressed in glioblastoma [107]. In addition, lymphoproliferative disorders were found
in transgenic mice overexpressing miR-17-92 [108]. Incidences of lung, colon, and gastric
cancers  were found to be correlated with the overexpression of  miR-17-92 cluster  [109].
LncRNAs have been associated with cancer development likewise. The lncRNA MALAT1
is up-regulated in several  cancer types,  resulting in an increase in cell  proliferation and
migration  in  lung and colorectal  cancer  cells  [105].  The  role  of  MALAT1 in  controlling
alternative  splicing of  pre-mRNAs [86]  can be deduced from this.  A more recent  study
indicates  that  MALAT1 may also  participate  in  the  regulation  of  gene  expression  by  a
mechanism other than alternative splicing in lung metastasis [110].
Other studies have shown that miRNA and lncRNAs both can function as tumor suppressor
genes or oncogenes. The tumor suppressor gene p53 regulates the three gene members of the
Figure 2. Posttranscriptional gene silencing by lncRNA and miRNA (adapted from Gomes et al. [130]).
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miR-34 family. Curiously, the microRNA-34 (miR-34) activation resembles p53 activity, such
as the induction of cell cycle arrest and promotion of apoptosis, and p53-mediated apoptosis
becomes defective in the absence of miR-34 [111].
LncRNAs that recruit epigenetic modifiers to specific loci such as ANRIL, XIST, HOTAIR, and
KCNQ1OT1 are found to have altered expression in a variety of cancers [112]. Another lncRNA
called TERRA binds telomerase, inhibiting its activity in vitro [113], and is observed to be down-
regulated in many cancer cells, linking it with the longevity of cancer cells.
Chromatin remodeling by lncRNA is linked to other diseases such as facioscapulohumeral
muscular dystrophy (FSHD) [97], lethal lung developmental disorder [114], and the HELLP
syndrome, a pregnancy-associated disease [114] in addition to cancer. The HELLP stands for
H = hemolysis (breakdown of red blood cells), EL = elevated liver enzymes (liver function),
and LP = low platelet counts (platelets help the blood clot). These examples directly link
lncRNA and miRNAs in cancer biology and other human diseases and indicate the involve‐
ment of a complex interplay among their biogenesis pathways, their regulatory mechanisms,
and their targets.
Figure 3. Relationship among various noncoding RNAs and different disorders caused by them (adapted from Gomes
et al. [130].
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12. Dosage compensation and X inactivation
X chromosome inactivation (XCI) occurs in females during embryogenesis, where either the
maternal or paternal X chromosome is randomly silenced. The molecular mechanisms of XCI
are not yet fully understood. However, it is known that a 500-kb stretch of DNA at Xq13 known
as the X-inactivation centre (XIC) is the site for initiation of X inactivation. There are several
lncRNAs, including X-inactive specific transcript (Xist), its antisense transcript Tsix, X-
inactivation intergenic transcription elements (Xite), Jpx transcript, and Xist activator (Jpx),
and others play pivotal roles in XCI [115]. Xist was one of the first to be identified and best
studied lncRNAs. It is a ~17-kb transcript (~19 kb in humans) expressed from the future inactive
X chromosome (Xi) [116]. Tsix is a ~40-kb antisense transcript to Xist. It negatively regulates
Xist. Recent studies indicate that Xite is a transcriptional enhancer of Tsix [115], and likewise,
Jpx RNA appears to help in Xist expression [117].
When two homologous X chromosomes are brought at close proximity, Tsix and Xite initiate
the inactivation process by counting, and this is associated with the presence of RNA poly‐
merase II (RNAPII) [118, 119]. The chromatin insulator CTCF, which binds to Tsix and Xite
genomic loci [120], play an important role. The transcription factor OCT4 is then hypothesized
to bind with Tsix promoters of one of the X chromosomes, which then converts to active X
chromosome (Xa) due to increased transcription of Tsix [120]. Thereafter, Dnmt3a is recruited
to the Xa and establishes stable silencing of Xist on the Xa [115, 118].
13. LncRNA in genomic imprinting
In mammals, genomic imprinting is an epigenetic marker in a way that their expression
occurs specifically in parental  origin manner.  This occurs during early gametogenesis in
nearly 1% of protein-coding genes. To date, we have identified around 150 imprinted genes
in mice. Imprinted genes are often located in clusters of size from a few kilobases to 2 to
3 Mb. LncRNAs are present in all the identified and elucidated imprinted clusters as their
partners.  The  expression  of  lncRNAs is  reciprocally  linked with  corresponding  protein-
coding genes [121–123].
Genomic imprinting mainly happens by chromatin insulators [124–126] and lncRNAs [38,
127]. LncRNAs repress flanking gene promoters in cis action (Kcnq1ot1 and Airn lncRNAs
[115]). However, several reports indicate that lncRNAs function as a major force in the
regulation of parent-of-origin-specific expression. Today, we know that the human genome
contains more than 58,648 lncRNA expressed genes compared to only 21,313 protein-coding
genes [128]. The majority of the lncRNAs act by interacting with chromatin-modifying
complexes such as PRC2, G9a, hnRNPK, and SWI/SNF, recruiting them sequentially to silence
genes in cis or trans action [57, 60].
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14. Perspectives
LncRNA has diversified tentacles for functions. Those include an alteration of transcriptional
profiles, controlling of protein expression, complex structural or organizational roles, RNA
processing or RNA editing and role of being the precursor of small RNAs. Because a very small
fraction of lncRNA have been molecularly characterized to date, many more yet to be discov‐
ered that fit into this diversified functional paradigms. Future work will definitely ask many
more questions about the interplay of lncRNA transcripts and whether it is sufficient to have
fundamental sequence of events or not. Many lncRNAs play intermediate roles in cis regulation
that gets represented in ectopic expression in trans regulation.
Most recent challenges are to identify how the molecular function of each type of lncRNA
results in different diseases of the organism. LncRNA appears to expose numerous develop‐
mental events such as the generation of photoreceptor cells in retina development, control of
cell surveillance, cell cycle progression of mammary gland development, and finally genera‐
tion of knockout animal development. Many lncRNAs are not eliminated as transcriptional
noise in the genome but are useful for normal developmental processes.
LncRNA has a tremendous impact on disease development due to its flawless miscegenation.
In tumor formation, the expression of lncRNAs is very important. They function like specific
markers of tumor formation. However, the exact mechanism by which tumor initiation,
formation, and progression would occur is not fully understood. It is true that the interplay
and significant role of lncRNA in different disease research is really an unexplored area, which
is eventually determining the new therapeutic targets. Recently, it was found that lncRNA
may form β-amyloid plaques in Alzheimer’s disease. This possibility suggested that noncoding
transcript might serve as an attractive drug target for Alzheimer’s disease.
Most conventionally, genetic information may run through protein-coding sequences, but it
is now found that transcription is pervasive through the nucleic acid content of eukaryotic
genome, which generated a numerous number of lncRNA, which are possibly the key
regulators of protein-coding sequences. We anticipate that many more surprises are yet to be
explored in the coming decades. Therefore, future research might provide more pleasant but
unexpected surprises in the lncRNA function.
15. Conclusion
The above description exhibits a brief survey of the current status of knowledge regarding the
identification, localization, functions, and mechanisms of actions of lncRNAs related to
different human diseases. A fraction of genomic nucleic acid is transcribed to protein, but an
overwhelming majority of the genome sectors of the organisms contain lncRNA with unknown
functional efficacy. Some are nuclear or cytoplasmic and are highly overexpressed, and others
are rarely detected. Truly, it is impossible to discern the important criteria such as stability,
conservation, and time of expression related to human diseases. LncRNA in the Xic is only
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found in placental mammals and is not conserved in other mammals. However, this limited
conservation might not be essential in other higher animals. The true test for real function lies
in the mechanism, genetic pathway, and tissue-specific activity for each lncRNA. The genome
of an organism is not always streamlined by the natural selection. Thus, here, we really tried
to avoid the speculative statements about localization, function, and dissecting mechanism
regarding long noncoding RNA. Truly, we have just begun to scratch the skin of LncRNA in
the human body. The lncRNA world is so galactically vast that we have an enormous task to
completely learn about it. We feel that additional discoveries of lncRNA may provide a real
exciting phase in the study of RNA world.
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